Orion Investment Co

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2033920 ST. LOUIS, MO

Position in REGN

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$23,825,899

+$43,041 QoQ

Shares Held

30,837

+0.1% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

7.72%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Orion Investment Co holds $51,893,657 across 4 Biotechnology names. REGN ranks #1 (45.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	30,837	$23,825,899
2	IONS	Ionis Pharmaceuticals Inc	225,015	$16,896,376
3	IOVA	Iovance Biotherapeutics, Inc.	2,065,652	$7,250,438
4	ARWR	Arrowhead Pharmaceuticals, Inc.	62,535	$3,920,944

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,825,899	30,837	+0.1%	Shares	Sole	2026-05-12
2025-12-31	$23,782,858	30,812	+0.6%	Shares	Sole	2026-02-11
2025-09-30	$17,226,265	30,637	+1.2%	Shares	Sole	2025-11-13
2025-06-30	$15,892,275	30,271	-0.9%	Shares	Sole	2025-08-14
2025-03-31	$19,382,703	30,561	+2.3%	Shares	Sole	2025-05-14
2024-12-31	$21,288,694	29,886	+1.7%	Shares	Sole	2025-02-13
2024-09-30	$30,891,738	29,386	-0.3%	Shares	Sole	2024-11-13
2024-06-30	$30,992,772	29,488	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.